Related Experiment Video
Updated: May 29, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
BioBanking - The Holy Grail of novel drug and diagnostic developments?
1Div, Clinical Protein Science & Imaging, Dept, of Measurement Technology and Industrial Electrical Engineering, Lund University Biomedical Center, BMC C13 SE-221 84 Lund, Sweden. Gyorgy.Marko-Varga@elmat.lth.se.
Abstract:
The ever increasing social cost that society pays for illness and disease are currently steadily increasing in many countries in the world today. These changes in society becomes a major financial burden that activates politicians and health care organizations in order to find new solutions. Biobanks are becoming the new powerful modality within the field of modern Life Science, that is expected to be important in the proactive awareness of patient health status. Biobanks are also expected to promote the developments of targeted treatments with personalized indicator assays, for effective use of Personalized Medicine treatments in the near future.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Bioavailability Study Design: Healthy Subjects Versus Patients
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
Measurement of Bioavailability: Pharmacodynamic Methods
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

